(Q44410698)

2 December 2017

title

Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice (English)

1 reference

2 December 2017

0 references

5

Fatih M Uckun

1 reference

2 December 2017

author name string

Marina Cetkovic-Cvrlje

1

1 reference

2 December 2017

Angela L Dragt

2

1 reference

2 December 2017

Alexei Vassilev

3

1 reference

2 December 2017

Xing-Ping Liu

4

1 reference

2 December 2017

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

106

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

213-225

1 reference

An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Interleukin-13 prevents autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Jaks and Stats in signaling by the cytokine receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Defective lymphoid development in mice lacking Jak3

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Jaks and STATs: biological implications

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Cytokine-independent Jak3 activation upon T cell receptor (TCR) stimulation through direct association of Jak3 and the TCR complex

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

The role of CD4 vs. CD8 T cells in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Suppression of primary T-cell responses and induction of alloantigen-specific hyporesponsiveness in vitro by the Janus kinase inhibitor tyrphostin AG490

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Human autoimmune diabetes mellitus: lessons from BB rats and NOD mice--Caveat emptor

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Suppression of autoimmune diabetes by viral IL-10 gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Mechanisms of interleukin-10-mediated immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Antigen based therapies to prevent diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Tolerance to islet autoantigens in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Preventive effects of cyclosporin on diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900049-9

7 January 2021

10.1016/S1521-6616(02)00049-9

Identifiers

DOI

1 reference

2 December 2017

1 reference